HSKA - /C O R R E C T I O N -- Heska Corporation/
PR Newswire
In the news release, Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023 , issued 08-Feb-2023 by Heska Corporation over PR Newswire, the conference call United States phone number was missing a digit, the correct phone number is 1-877-451-6152 rather than 1-877-41-6152 as incorrectly transmitted by PR Newswire. The complete, corrected release follows:
Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023
LOVELAND, Colo. , Feb. 8, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its fourth quarter and full year 2022 financial performance in a press release before the market opens on Tuesday, February 28, 2023 . The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.
To access the conference call:
From within the United States , please dial 1-877-451-6152
From outside of the United States , please dial 1-201-389-0879
Reference Conference ID: 13736218
The earnings call will be webcast live from the Company's investor relations website at: Heska Fourth Quarter and Full Year Earnings Call Webcast .
A telephonic replay will be available at 2 p.m. ET on February 28 th through 11:59 p.m. ET on March 14, 2023 and the webcast will be archived on the Company's website for 90 days.
To access the replay by telephone:
From within the United States , please dial 1-800-512-2921
From outside the United States , please dial 1-412-317-6671
Reference Replay Pin Number: 13736218
About Heska
Heska Corporation (NASDAQ: HSKA) sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. Heska's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products; digital cytology services; point-of-care digital imaging diagnostic products; local and cloud-based data services; practice information management software ("PIMS") and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska's primary focus is supporting companion animal veterinarians in providing care to their patients. Heska's business is composed of two operating and reportable segments: North America and International. North America consists of the United States , Canada and Mexico . International consists of geographies outside of North America , primarily in Germany , Italy , Spain , France , Switzerland , Australia and Malaysia . The Company's strategic focus on point-of-care diagnostic laboratory and imaging products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the International segment includes PIMS business and veterinary laboratories. For more information, please visit www.heska.com .
SOURCE Heska Corporation
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by PR Newswire via Quote Media. Read our full disclaimer.